← All organizations

Alebund Pharmaceuticals

For profit

Also known as: Alebund Pharmaceuticals | Shanghai Alebund Pharmaceuticals Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 13, 2025

Timeline

2010s

Jun 1, 2018
Alebund Pharmaceuticals— Founded

Drugs by trial phase (6 distinct, 7 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

bufalin

Indications

Studied for

Hyperphosphatemia

Recent trials (7)

NCT06933472Lead sponsorPhase 3Jun 13, 2025
NCT06712654Lead sponsorPhase 2Apr 10, 2025
NCT06666283Lead sponsorPhase 1Nov 5, 2024
NCT06308523Lead sponsorPhase 1Mar 18, 2024
NCT07030595Lead sponsorPhase 3Jun 12, 2023
NCT05764590Lead sponsorPhase 2Feb 20, 2023
NCT04551300Lead sponsorPhase 2Oct 13, 2020

Details

Founded: Shanghai, CN Jun 1, 2018
Last known activity: Jun 13, 2025